This announcement is a separate document:
海南海药：关于全资子公司获得枫蓼肠胃康口服液药品补充申请批件暨成为药品上市许可持有人的公告
Hainan Haiyao: Announcement on the Wholly-owned Subsidiary Obtaining Supplemental Application Approval for Fengliao Gastroenterology Oral Liquid and Becoming a Drug Marketing License Holder
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.